Axsome Therapeutics, Inc.

SEC 4 · Filed

0001193125-26-045110Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 10, 2026

Exercise or conversion by Coleman Mark

Security
Stock Option (Right to Buy)
Code
M
Shares
5,193
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-02-10",
  "direction": "D",
  "exercise_price": "8.02",
  "expiration": "2026-05-27",
  "footnotes": {
    "F1": "Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."
  },
  "owners": [
    {
      "cik": "0001658379",
      "name": "Coleman Mark",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "0",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock Option (Right to Buy)",
  "shares": "5193",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "5193"
}
Insider transactionsEvent date Feb 10, 2026

Exercise or conversion by Coleman Mark

Security
Common Stock
Code
M
Shares
5,193
Price per share
8.02
Structured facts
{
  "code": "M",
  "date": "2026-02-10",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."
  },
  "owners": [
    {
      "cik": "0001658379",
      "name": "Coleman Mark",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "53405",
  "price": "8.02",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "5193",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}